Sitaglu Met XR Tab 50/500 14’s

Sitagliptin will decrease postprandial blood glucose and mildly lower fasting blood glucose for a total A1C reduction around 0.8 percent. It is more expensive than other options, such as sulfonylurea hypoglycemics. It is not known whether sitagliptin has any effect on diabetes-related morbidity or mortality.

Uses of Sitaglu Met XR Tab 50/500 14’s

Monotherapy: This medicine is used for treating type 2 diabetes (condition characterized by elevated glucose levels) that is inadequately controlled by metformin, diet and exercise.

Dual therapy: It is used for treating diabetes type 2 along with metformin or a glitazone when patients respond inadequately to diet changes, exercise and either metformin or glitazine, or in combination with sulphonylureas in patients contraindicated for metformin, and for patients that do not respond adequately to sulphonylureas alone.

Triple therapy: This medicine is used with metformin and a sulphonylureas or glitazone for treating diabetes 2 that is inadequately controlled by dual therapy.

With insulin: This medicine is used with or without metformin for treating type 2 diabetes in patients who respond inadequately to diet, exercise, and insulin.

Side Effects

Some patients administered with this medication might experience,

• Nausea
• Vomiting
• Diarrhoea and stomach pain.

Please consult your doctor if you experience any of these symptoms.

When Not To Use

The patients with diabetic ketoacidosis (condition causing fat breakdown at an abnormal rate) and moderate to severe renal (kidney) impairment should avoid use of this medicine.